Location hours
Open
- Sunday:
- Closed
- Monday:
- 8:00 am - 5:00 pm
- Tuesday:
- 8:00 am - 5:00 pm
- Wednesday:
- 8:00 am - 5:00 pm
- Thursday:
- 8:00 am - 5:00 pm
- Friday:
- 8:00 am - 5:00 pm
- Saturday:
- Closed
41.7173467, -93.6197742
Services at this location
Show more
Our Care Team
Need help selecting a provider?
When you call 1-515-282-2921 we'll help you find a provider who meets your needs.
Clinical Trials
Mission Cancer + Blood offers a variety of cancer clinical trials at our Ankeny, Magazine Road location.
Patient Stories
September 29, 2026
West Des Moines resident Amy Randall reflects on her breast cancer journey with Mission Cancer + Blood, part of University of Iowa Health Care.
September 24, 2026
After surgery, hormone therapy, and radiation fell short, Ron Watson found a new way forward through theranostics — a targeted approach that he was ab...
Educational Resources
Awards and Recognition
U.S. News & World Report - Colon cancer surgery, lung cancer surgery, and prostate cancer surgery
In 2026-27 our colon cancer surgery, lung cancer surgery, and prostate cancer surgery programs were identified as High Performing by U.S. News & World Report.
U.S. News & World Report - No. 1 in Iowa for Cancer Care
We are proudly ranked No. 1 in Iowa for Cancer Care in the 2026–27 “Adult, Best Hospitals” report.
U.S. News & World Report - Leukemia
In 2026-27 our leukemia program was identified as High Performing by U.S. News & World Report.
U.S. News & World Report - Colon cancer surgery, lung cancer surgery, and prostate cancer surgery
In 2026-27 our colon cancer surgery, lung cancer surgery, and prostate cancer surgery programs were identified as High Performing by U.S. News & World Report.
U.S. News & World Report - Colon cancer surgery, lung cancer surgery, and prostate cancer surgery
In 2026-27 our colon cancer surgery, lung cancer surgery, and prostate cancer surgery programs were identified as High Performing by U.S. News & World Report.
U.S. News & World Report - Lymphoma
In 2026-27 our lymphoma program was identified as High Performing by U.S. News & World Report.
U.S. News & World Report - Myeloma
In 2026-27 our myeloma program was identified as High Performing by U.S. News & World Report.
U.S. News & World Report - Colon cancer surgery, lung cancer surgery, and prostate cancer surgery
In 2026-27 our colon cancer surgery, lung cancer surgery, and prostate cancer surgery programs were identified as High Performing by U.S. News & World Report.